| Join Our Mailing List |
The goal of the GEANCO Foundation is to educate Africans in medicine. So, we've assembled a series of talks from heavy hitters in the fields of HIV and Malaria research and treatment. We hope that Africans, and anyone else interested in learning about these devastating global diseases, will enjoy this online symposium. Please contact us with your thoughts.
David Baltimore, Ph.D., Nobel prize-winning discoverer of the molecule that HIV uses to copy itself into our DNA, discusses the origins of HIV, the failure to find a cure, and his own approach toward treatment.
Kimberly Shriner, M.D. , leader of the Phil Simon Clinic Tanzania project, discusses the difficulties and rewards of ministering to HIV positive patients in Africa.
Joel Breman, M.D., D.T.P.H., Senior Scientific Advisor at the Fogarty International Center of the NIH, discusses the battle against Malaria.
Bruce Hay, Ph.D., Caltech Associate Professor of Biology, explains a new way to spread genetically-engineered malaria-resistance throughout the African mosquito population.
Martha Sedegah, Ph.D., Senior Scientist at the NMRC's Malaria program, discusses two promising new malaria vaccines.
And, make sure to check out GEANCO COO Afam Onyema's talk on building a state-of-the art hospital in Nigeria.
The 2008 symposium was made possible with the generous co-sponsorship of 89.3 KPCC, the Caltech Y and the Caltech Alumni Association.
David Baltimore, Ph.D., Nobel prize-winning discoverer of the molecule that HIV uses to copy itself into our DNA, discusses the origins of HIV, the failure to find a cure, and his own approach toward treatment.
Kimberly Shriner, M.D. , leader of the Phil Simon Clinic Tanzania project, discusses the difficulties and rewards of ministering to HIV positive patients in Africa.
Joel Breman, M.D., D.T.P.H., Senior Scientific Advisor at the Fogarty International Center of the NIH, discusses the battle against Malaria.
Bruce Hay, Ph.D., Caltech Associate Professor of Biology, explains a new way to spread genetically-engineered malaria-resistance throughout the African mosquito population.
Martha Sedegah, Ph.D., Senior Scientist at the NMRC's Malaria program, discusses two promising new malaria vaccines.
And, make sure to check out GEANCO COO Afam Onyema's talk on building a state-of-the art hospital in Nigeria.
The 2008 symposium was made possible with the generous co-sponsorship of 89.3 KPCC, the Caltech Y and the Caltech Alumni Association.
Check out the speakers from our previous symposium on HIV and Malaria and our upcoming symposium on Maternal and Infant Health.
The GEANCO Foundation is a 501(c)(3) tax-exempt organization. All donations made to the GEANCO Foundation are tax deductible to the fullest extent of the law.